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(US/UK). Patients also provided their opinions of current CT
with DFO to ensure that no major concepts were omitted.
RESULTS: The literature review revealed no IO or CT speciﬁc
questionnaires, though several articles recounted DFO’s incon-
venience and impact. Patient and clinician interviews suggested
that patients were most concerned about the efﬁcacy, side effects,
convenience and costs of any new IO treatment. Satisfaction with
DFO was low, primarily due to local site reactions, inconve-
nience, and the constraining nature of the therapies. Presented
with a hypothetical oral CT, patients unanimously preferred oral
CT. A 40-item questionnaire was developed that assessed
patients’ expectations of and satisfaction with attributes identi-
ﬁed as important including efﬁcacy, safety, convenience and side
effects, along with costs, overall satisfaction, treatment impact,
patient compliance, and preferences. Results from the content
validity testing resulted in additions to the instructions and the
rewording of six items. CONCLUSIONS: To accurately assess
satisfaction, patient input should be obtained. In the absence of
real-life experience with the proposed therapy, unbiased hypo-
thetical product proﬁles were used to elicit the dimensions
important to patients, and this is consistent with established
methods. Psychometric validation is currently underway.
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OBJECTIVE: Item response bias (also called differential item
functioning, DIF) in Instrumental Activities of Daily Living
(IADL) occurs when members of different groups possessing the
same disability level do not have the same probability of
responding positively for a given item(s). This study aimed to
identify the extent of DIF by gender, age, ethnicity and demen-
tia groups in IADL estimates in Asian (Chinese, Malay and
Indian) elderly subjects. METHODS: Data of the 2003 National
Mental Health Survey were analyzed from 1072 non-institu-
tionalized elderly subjects using multiple indicator–multiple
cause latent variable (MIMIC) modeling. RESULTS: Given the
same functional level, older elderly were less likely to report
receiving help with preparing meals; men were more likely to
report receiving help with preparing meals, doing laundry, and
taking medication; Malays were more likely to report receiving
help with using telephone; and demented elderly were more
likely to report receiving help with using telephone, managing
money, taking medications, and “getting around”. The impact
of DIF on group differences was highest for gender (54.0%), eth-
nicity (42.9%), dementia (14.7%) and age (2.4%). CONCLU-
SION: Item-response bias in IADL estimates by gender, age,
ethnicity and dementia should be considered in direct compar-
isons of disability status among population groups.
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OBJECTIVES: To conduct a cost analysis of current competing
strategies for the management of patients with closed and open
grade I tibial shaft fractures, from both a governmental and soci-
etal perspective. METHODS: Our cost analysis was performed
for four competing treatment strategies for management of
closed or grade I open tibial fractures: 1). casting alone; 2).
casting with therapeutic ultrasound; 3). operative treatment with
non-reamed intramedullary nailing; and 4). operative treatment
with reamed intramedullary nailing. The time to radiographic
fracture union was used as the measure of effectiveness. Given
the multiple clinical alternatives, each with the potential to result
in a number of outcomes, a decision tree was used to perform
all cost analyses. Sensitivity analysis was conducted through
Monte Carlo simulations. RESULTS: From a governmental per-
spective the mean associated costs were USD $3365 (standard
deviation [SD] ± 1425) for operative management by reamed
intramedullary nailing, $5041 (SD ± 1363) for operative man-
agement by non-reamed intramedullary nailing, $5017 (SD ±
1370) for casting, and $5312 (SD ± 1474) for casting with 
therapeutic ultrasound. From a societal perspective the mean
associated costs were ($12,449; SD ± 4894) for reamed
intramedullary nailing, ($13,266; SD ± 3692) for casting with
therapeutic ultrasound, ($15,571; SD ± 4293) for operative man-
agement by non-reamed intramedullary nailing, and ($17,343;
SD ± 4784) for casting alone. CONCLUSIONS: Our preliminary
cost analysis suggests that, from both a governmental and soci-
etal perspective, reamed intramedullary nailing is the treatment
of choice for closed and open grade I tibial shaft fractures.
However, there is evidence that, from a societal perspective,
treatment of low energy tibial fractures with therapeutic 
ultrasound and casting may also be an economically-sound 
intervention.
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OBJECTIVES: To assess, in the Belgian setting, the costs, efﬁ-
cacy, and cost-effectiveness of zoledronic acid 5mg (Aclasta)
versus conventional therapies (tiludronate (Skelid), pamidronate
(Aredia), and risedronate (Actonel)) in the management of
patients with Paget’s disease of bone (PDB). METHODS: Based
on efﬁcacy data from pivotal zoledronic acid 5mg clinical trials
and the literature, a decision tree model was developed to reﬂect
the treatment path with the different drugs compared. This
model takes into account four health states and links efﬁcacy
data to Belgian resource use data. It covers a 2-year time horizon.
The outcome measure chosen is time in response, deﬁned as time
in which serum alkaline phosphatase is controlled. Direct
medical costs, from the perspective of the health care payer
(INAMI/RIZIV) were considered and discounting was applied in
the second year. The consumption of medical resources (drug
treatments including administration costs, laboratory tests, and
physician consultations) was assessed via expert opinion.
RESULTS: Over two years, the expected average numbers of
months in response for patients treated with zoledronic acid 5
mg and conventional treatments (tiludronate, pamidronate, and
risedronate) are: 20.9 months; 11.1 months; 9.3 months; and
16.2 months, respectively. Over this period, the expected average
costs for patients treated with zoledronic acid 5mg and conven-
tional treatments (tiludronate, pamidronate, and risedronate)
are: €686; €1525; €1245; and €793, respectively. Hence, zole-
dronic acid 5mg dominates all the other bisphosphonates com-
pared, i.e. zoledronic acid 5mg is less costly and more effective.
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This is mainly due to the lower average number of treatment
cycles needed with zoledronic acid 5mg, also considering the
improved compliance with the IV infusion. The probabilistic sen-
sitivity analyses performed show that the results are robust.
CONCLUSION: Based on our evaluation, in PDB, zoledronic
acid 5mg is both more effective and less costly than the other
bisphosphonates currently reimbursed in Belgium.
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OBJECTIVES: The objective of this study was to develop a ﬂex-
ible health economic simulation Markov cohort model that can
be used to assess the cost-effectiveness of different treatment
strategies within the hip and knee arthroplasty area in Sweden.
METHODS: The Markov cohort model included the following
health states: No event, Revision, re-revision and dead. The
model have stochastic capabilities and the uncertainty in the risk
of revision, mortality after revision, costs and quality of life were
accounted for by bootstrapping technique. For exempliﬁcation
the model was used to estimate the cost-effectiveness of a
cemented implants with antibiotics compared to cemented
implants without antibiotics in a Swedish setting for both
patients with THA and TKA. Data used to populate the model
was mainly derived from the Swedish National Hip Arthroplasty
Register and the Swedish Knee Arthroplasty Register and the
Swedish National Inpatient Register. The analysis had a societal
perspective (i.e. the aim is to include all relevant costs irrespec-
tive of who incur them). In the base case simulations patient were
followed for 10 years after the arthroplasty. RESULTS: An
antibiotic cemented implant compared to an implant without
antibiotics was found cost saving both for patients having a THA
and TKA was found to be cost saving when patients were fol-
lowed for 10 years after the procedure in the model. When the
costs in added life were included the cost per QALY gained was
SEK 187,888 for THA and SEK 186,217 for TKA. CONCLU-
SIONS: The developed cost-effectiveness model indicated that
antibiotic cemented implants compared to implants with no
antibiotics was cost-effective for the use in THA and TKA. The
model is highly adaptable for the evaluation of other treatments
strategies such as prostheses but it can also be used to evaluate
waiting times or the procedure as a whole.
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OBJECTIVES: To examine trends of prevalence and treatment
patterns of diabetes mellitus (DM) in adults and to determine the
relationship between DM and obesity. METHODS: This study
used Third National Health and Nutrition Examination Survey
(NHANES III for 1988–1994) and NHANES 1999–2002, rep-
resenting a national sample of the non-institutionalized civilian
US population. Adult DM patients were identiﬁed if they were
≥20 years old, and were previously diagnosed with DM by a
physician or currently using DM therapy (hypoglycemic
agent/insulin). These patients were classiﬁed as obese if body
mass index ≥30. Nationally representative prevalence was esti-
mated using sample weights. Data were analyzed using SAS and
SUDAAN statistical softwares to adjust for the complex sample
design. RESULTS: The age-adjusted prevalence of DM was 6.8%
in 1999–2002 compared to 5.4% in 1988–1994 (p < 0.001).
Approximately 51.6% of DM patients were obese in 1999–2002
(44.1% in 1988–1994). During 1999–2002, DM was more
prevalent in patients aged 65–74 (16.31%) and was increased
most rapidly in this age group (4.5% increase; p < 0.05). DM
was most prevalent in Whites (61%; 12.7% decrease from
NHANES-III; p < 0.05), followed by Blacks (16%; 1% increase),
and Hispanics (16%; 10% increase; p < 0.05). More obese DM
patients were treated with medication than non-obese DM
patients (84% vs. 80%). During study period, DM patients who
received treatment signiﬁcantly increased by 8% (p < 0.01; 6%
in obese), but 62% of these patients’ A1c was still uncontrolled.
DM patients often have comorbidities of hypertension (67%;
4% increase), followed by hyperlipidemia (48%; 12% increase),
and retinopathy (27%; 11% increase) and these comorbidities
are more prevalent in obese DM patients. CONCLUSIONS: DM
has become very rapidly prevalent in US adults, with the great-
est increase in Hispanics. Approximately half of DM patients did
not have their A1C level controlled and one-ﬁfth still did not
receive treatment. DM patients who were obese were less likely
to control their A1c compared to overall DM patients.
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OBJECTIVES: To estimate prevalence trends of overweight and
obesity and to assess relationship between weight status and
physical activity in adults ≥20 years old. METHODS: Three
National Health and Nutrition Examination Surveys, NHANES
(II) for 1976–1980, NHANES (III) for 1988–1994, and
NHANES (IV) 1999–2002 were used. Based on body mass index
(BMI), adults were classiﬁed as overweight (BMI 25 to <30) or
obese (BMI ≥ 30). Duration of physical activity was calculated
using leisure-time physical activity to determine compliance of
CDC recommendations. SAS and SUDAAN softwares were used
to account for the complex survey designs. RESULTS: The mean
BMI increased from 25.31(II) to 28.02(IV). During the study
period of II–IV, the prevalence of overweight and obesity
changed from 31.4% to 34.7% and from 14.5% to 30.2%,
respectively. Obesity signiﬁcantly increased 7.8% for II–III (p <
0.001) and 7.9% for III–IV (p < 0.001). The prevalence of over-
weight individuals increased most rapidly in adults 20–39 years
old. Obesity increased most rapidly in patients 40–64 years old
for II–III and 20–39 years old for III–IV. Hypertension was more
prevalent in obesity (75.2%(II), 50.7%(III), 48.0%(IV)) than
overweight (54.5%(II), 33.7%(III), 34.1%(IV)), yet for both
groups decreased over time. During IV, overweight adults spent
an average of 240 minutes per week for physical activity, and
obese adults spent 170 minutes. Only 43.2% of overweight and
37.5% of obese took medications or followed physical activity
guideline to control weight. CONCLUSIONS: Two-thirds of
U.S. adults were considered to be overweight or obese. The
prevalence of overweight and obesity continuously increased
during the past 30 years and increased more rapidly in recent
years. It is recommended that aggressive interventions be initi-
ated to increase patient awareness so that more patients get
treated and follow physical activity guidelines to lose or control
weight.
